Overview

Insulin Glargine, INITIATE Metabolic and Economic Outcomes of Lantus

Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
To introduce initiation of glargine insulin treatment in primary care based on a patient education program. To show and compare feasibility of group education to individual education program.
Phase:
Phase 4
Details
Lead Sponsor:
Sanofi
Treatments:
Insulin
Insulin Glargine
Insulin, Globin Zinc